Citi resumes coverage on Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP) with a Hold. PT $26.
Citi analyst says, "We resume ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE